{"disease":{"id":"polyuria","name":"Polyuria","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"desmopressin","indication_name":"Post-Trauma/Surgery Polyuria and Polydipsia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ddavp","generic_name":"DESMOPRESSIN","company_name":"Ferring Pharms Inc","drug_phase":"marketed","molecular_target":"Vasopressin V1b receptor","drug_class":"Factor VIII Activator","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"minirin","indication_name":"Polyuria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Minirin","company_name":"Hormozgan University of Medical Sciences","drug_phase":"marketed","molecular_target":"Oxytocin receptor, Vasopressin V1a receptor, Vasopressin V1b receptor","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"desmopressin","indication_name":"Polyuria","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ddavp","generic_name":"DESMOPRESSIN","company_name":"Ferring Pharms Inc","drug_phase":"marketed","molecular_target":"Vasopressin V1b receptor","drug_class":"Factor VIII Activator","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04125186","title":"A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US","phase":"","overall_status":"COMPLETED","enrollment_count":10190,"lead_sponsor_name":"Ferring Pharmaceuticals","has_results":false},{"nct_id":"NCT04329975","title":"Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)","phase":"","overall_status":"COMPLETED","enrollment_count":1087,"lead_sponsor_name":"Ferring Pharmaceuticals","has_results":false},{"nct_id":"NCT06535386","title":"Polyuria Associated With Dexmedetomidine in Operating Room","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Hospital Privado de Comunidad de Mar del Plata","has_results":false},{"nct_id":"NCT07357324","title":"A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Nocturia Symptoms After Enucleation of the Prostate","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":136,"lead_sponsor_name":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","has_results":false},{"nct_id":"NCT03116191","title":"Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Sanwa Kagaku Kenkyusho Co., Ltd.","has_results":false},{"nct_id":"NCT06542198","title":"Mannitol-induced Release of Copeptin in Healthy Adults and Patients With Polyuria-Polydipsia Syndrome (MARS Study)","phase":"NA","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT03844217","title":"Copeptin After an Oral Stimulation With Macimorelin in Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"University Hospital, Basel, Switzerland","has_results":false},{"nct_id":"NCT04526340","title":"Food and Salt Handling in Diuresis","phase":"NA","overall_status":"COMPLETED","enrollment_count":21,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT04520477","title":"Watershift - Pilot Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT03858439","title":"Dietary Intervention in ADPKD on Tolvaptan","phase":"NA","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"McMaster University","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}